- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Obstructive Pulmonary Disorder in Australia
Total 572 results
-
PfizerTerminatedPulmonary Disease, Chronic ObstructiveAustralia, Canada, United Kingdom, Poland, Netherlands
-
Genentech, Inc.RecruitingChronic Refractory Cough (CRC) With Non-atopic Asthma | CRC With Atopic Asthma | Unexplained Chronic Cough | CRC With Chronic Obstructive Pulmonary Disease | CRC With Chronic Obstructive Pulmonary Disease With Chronic BronchitisUnited States, Australia, United Kingdom, Canada
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseNetherlands, Austria, Denmark, Norway, Sweden
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseKorea, Republic of, Poland, Germany, Philippines, Ukraine, Japan, United States, Australia, Canada, Slovakia, Taiwan, Russian Federation
-
Nuvaira, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)France, Belgium, Netherlands, Austria, Germany, United Kingdom
-
Aeris TherapeuticsCompletedLung Diseases | Emphysema | Pulmonary Emphysema | Chronic Obstructive Pulmonary Disease (COPD)Israel, Austria, France, Germany
-
The AlfredRoche Pharma AGWithdrawnHeart Failure | Chronic Obstructive Airway DiseaseAustralia
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Brazil, United Kingdom, Germany, Philippines, Denmark, Australia, Argentina, India, Belgium
-
Novartis PharmaceuticalsCompletedCOPDSpain, Germany, Belgium, Poland, South Africa, Australia, Greece, Israel, Sweden, Hong Kong, Thailand, Bulgaria, Singapore, Denmark, Finland, Hungary, Romania, Malaysia
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Colombia, Argentina, Germany, Spain, Turkey, Guatemala, Mexico, Australia, Denmark, South Africa, Philippines
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
Medical University of ViennaCompletedPulmonary Disease, Chronic ObstructiveAustria
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Austria, Belgium, Canada, France, Germany, Italy, Netherlands, South Africa, Spain, United Kingdom
-
Genentech, Inc.Active, not recruitingChronic Obstructive Pulmonary DiseaseUnited States, Israel, Australia, Denmark, Korea, Republic of, Spain, Belgium, France, Bulgaria, Poland, United Kingdom, Germany, Canada, Netherlands, Peru, Argentina, Hong Kong, South Africa, New Zealand, Sweden, Czechia, Austria, ... and more
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Argentina, Australia, Canada, Mexico, New Zealand, South Africa
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States, Australia, New Zealand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, Romania, Bulgaria, Germany, Netherlands, New Zealand
-
Arrowhead PharmaceuticalsRecruitingChronic Obstructive Pulmonary Disease | AsthmaKorea, Republic of, Australia, New Zealand, Poland, Thailand, Spain
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Australia, Germany, United Kingdom, China, Philippines, Italy, Chile, Taiwan, Thailand, France, Puerto Rico, Israel, Peru, Colombia, Poland, Brazil, Russian Federation, Romania, Greece
-
Aeris TherapeuticsTerminatedEmphysema | Chronic Pulmonary Obstructive DiseaseGermany, Israel, Austria, France
-
SanofiRegeneron PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUkraine, Argentina, Chile, Poland, Russian Federation, Turkey, United States, Australia, Canada, Germany
-
Apreo Health, Inc.RecruitingEmphysema or COPDAustralia
-
Hoffmann-La RocheRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, China, Spain, Italy, Germany, Belgium, Korea, Republic of, Poland, Taiwan, Israel, New Zealand, Sweden, United Kingdom, Japan, Czechia, Philippines, Hong Kong, Greece, Australia, Thailand, Netherlands, Argentina, Brazil, Fran... and more
-
AstraZenecaCompletedA Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease (COPD)Andorra, Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Pulmonx CorporationRecruitingEmphysema or COPD | Emphysema, PulmonarySpain, Germany, Italy, Australia
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)China, Denmark, United States, Australia, Germany, Netherlands, Poland, Spain, United Kingdom, Korea, Republic of, Philippines, Italy, Argentina, Belgium, Bulgaria, Canada, Czechia, Finland, Hungary, India, Japan, Mexico, Norway, Port... and more
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Romania, Russian Federation, Slovakia, South Africa, Spain, Sweden, Ukraine, United Kingdom
-
Zuzana Zbožínková, M.Sc.Boehringer IngelheimCompletedChronic Obstructive Pulmonary DiseaseLatvia, Croatia, Austria, Bulgaria, Czech Republic, Hungary, Poland, Russian Federation, Serbia, Slovakia, Slovenia
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseRussian Federation, Singapore, United States, Canada, Korea, Republic of, Japan, Spain, Turkey, Romania, Australia, Netherlands
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Denmark, France, Sweden, Thailand, Vietnam, Belgium, Brazil, Peru, Philippines, Turkey, Taiwan, Argentina, Australia, Israel, Poland, Ukraine, Slovenia, Serbia, Mexico, Bulgaria, Colombia, New Zealand, Chile, Norway, Croatia
-
University Hospital of North NorwayUniversity of Tromso; The Research Council of Norway; The Alfred; Aalborg University and other collaboratorsCompletedPulmonary Disease, Chronic ObstructiveNorway, Denmark, Australia
-
Hoffmann-La RocheRecruitingChronic Obstructive Pulmonary DiseaseUnited States, Belgium, Australia, Israel, Spain, France, United Kingdom, Denmark, Argentina, Germany, New Zealand, South Africa, Korea, Republic of, Poland, Bulgaria, Canada, Chile, Czechia, Netherlands, Romania, Sweden, Mexico
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD) | Chronic BronchitisUnited States, Canada, Denmark, Spain, United Kingdom, Taiwan, New Zealand, Australia, Germany, Israel, South Africa, Czechia, Hungary, Poland, Netherlands
-
Otto Wagner HospitalCompletedPulmonary Disease, Chronic ObstructiveAustria
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)France, Denmark, Italy, Spain, United States, Canada, Argentina, Japan, Colombia, Germany, Peru, Brazil, China, India, Thailand, Austria, Serbia, Malaysia, Philippines, Poland, Taiwan, Greece, Norway, Sweden, Mexico, Romania, Korea, Republic... and more
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, Canada, New Zealand
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseFrance, Germany, Italy, Spain, United Kingdom, Austria, Hungary
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Austria, Canada, Germany, Greece, New Zealand, Norway, Slovakia, South Africa, Sweden
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Austria, Bulgaria, Canada, Czech Republic, France, Germany, Hungary, Italy, Lithuania, Netherlands, Poland, South Africa, Spain, United Kingdom
-
PfizerCompletedPulmonary Disease, Chronic ObstructiveAustralia, United Kingdom, Argentina, Germany, India
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Russian Federation, Taiwan, Canada, Germany, Philippines, South Africa, Spain, United Kingdom, Turkey, Hungary, Guatemala, Australia, Bulgaria, France, Poland, Switzerland, Slovakia, Japan
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseKorea, Republic of, Austria, Belgium, Germany, Greece, Russian Federation, Australia, Brazil, Canada, Denmark, France, Hungary, Israel, Italy, Netherlands, Poland, Slovakia, South Africa, Spain, Turkey, United Kingdom
-
PfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Sweden, Australia, Hungary, Bulgaria, South Africa, Poland, Slovakia, India, Canada, Argentina, Czech Republic, Chile, New Zealand, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustria, Germany, Canada, United States, Poland, Belgium, Portugal, United Kingdom, Australia, Denmark, New Zealand
-
Merck Sharp & Dohme LLCRecruitingChronic Obstructive Pulmonary Disease | Pulmonary HypertensionUnited States, Korea, Republic of, Australia, Germany, Spain, Italy, Switzerland, France, Argentina, Colombia, Israel, Austria, Mexico, United Kingdom, Belgium, Turkey, Peru, South Africa
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States, Spain, Switzerland, France, Italy, Germany, Turkey, Hungary, Norway, Slovakia, Poland, Russian Federation, Canada, Belgium, Austria, Colombia, Denmark, Finland, Greece, Israel, Mexico, United Kingdom